Both in Biotechnology
C4 Therapeutics vs Allogene Therapeutics
Over the past year CCCC returned +32.1% and ALLO returned −8.1%; their daily moves had a correlation of 0.28.
CCCC +32.1% ALLO −8.1%Growth of $1, one year, split-adjusted
| Metric | CCCC | ALLO |
|---|---|---|
| Price | $3.28 | $1.09 |
| Market cap | $402.9M | $374.9M |
| Today | −2.82% | −8.05% |
| 1 month | +11.0% | −27.7% |
| 6 months | +7.9% | −52.0% |
| Year to date | +71.5% | −20.8% |
| 1 year | +33.1% | −10.3% |
| Revenue growth (YoY) | +2.8% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −355.9% | −919.8% |
| P/E (TTM) | — | — |
| Price / sales | 11.5× | 80.8× |
| Net cash | $253.7M | $332.6M |
| Dividend yield | — | — |
| Volatility (60d) | 65.1% | 55.2% |
| Short % of float | 43.4% | 19.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).